Think a pill that packs two cholesterol-lowering drugs in one potent package is a good idea? The Food and Drug Administration thinks so. It recently approved the combination of the popular statin drug Lipitor (atorvastatin) with another ...
Health Canada has announced the labeling update for all cholesterol-lowering drugs (statins). The update warns about the risk of increased blood sugar levels and an increased risk of diabetes among patients with pre-existing risk factors ...
Let's hope that the pounding you feel in your chest today is love. But let's face it, while it may not seem romantic, the best gift you can give a loved one is a healthy heart. So here are five simple things you can do to keep your heart ...
Tags: Valentine's Days, healthcare, health
Health Canada will inform Canadians of a labeling update for all cholesterol-lowering drugs, which are also known as statins, regarding the risk of increased blood sugar levels and a small increased risk of diabetes among patients who are ...
Tags: drug labels, Healthcare, statins
Genzyme, a Sanofi company, has submitted a new drug application to the FDA seeking approval for KYNAMRO for the treatment of patients with homozygous familial hypercholesterolemia (HoFH). The submission is based on trial in which ...
Tags: KYNAMRO, homozygous familial hypercholesterolemia, HoFH
Dr. Reddy's Laboratories, an integrated global pharmaceutical company, has introduced Atorvastatin Calcium tablets 10mg, 20mg, 40mg and 80mg in the US. The Atorvastatin Calcium tablets, approved by the United States Food & Drug ...
Tags: anti-cholesterol drug, Atorvastatin Calcium tablets, Lipitor tablets
Capstone Therapeutics and LipimetiX have formed LipimetiX Development , a joint venture (JV), to develop drugs that are used to treat indications of lowering blood cholesterol levels. The JV will develop a family of Apo E mimetic peptides ...
Tags: Apolipoprotein E, lipoprotein metabolism, Capstone Therapeutics